Liver problems — XALKORI may cause life-threatening liver injury that may lead to death. Your healthcare provider should do blood tests to check your liver every 2 weeks during the first 2 months of treatment with XALKORI, then once a month. Tell your healthcare provider right away if you get any of the following new or worsening symptoms:

<strong>Support Resources</strong>

Title: 
Resources
Body: 

If you’d like more information about XALKORI® (crizotinib), non-small cell lung cancer (NSCLC), or the oncology patient experience, you may want to start with the following downloads and links.

Title: 
Printable Resources
Body: 

You can download and print these useful documents. They'll help educate you on what to expect while taking XALKORI and how to navigate the cancer experience.

Brochure

This brochure will provide information about XALKORI as a treatment for ALK-positive (ALK+) or ROS1-positve (ROS1+) metastatic NSCLC to help you get the most out of your treatment and understand what to expect.

Download
PP-UNP-USA-2823_Unbranded Patient Experience Brochure-Digital_L4_Page_01
Patient Guide for Navigating the Cancer Experience

This dynamic resource is meant to guide patients through the many different experiences of living with cancer, including how to talk about their diagnosis, facing strong emotions, and advocating for their own physical and mental health, as well as their care partner’s wellbeing. This resource may be helpful for any cancer patient or care partner regardless of which treatment they are on. It is not specific to XALKORI.

Download
Title: 
Useful links
Body: 

Additional education and support for your treatment journey

If you’d like to explore other resources to learn more about cancer care and how it’s changing, consider the following:

It's also a good idea to check with your hospital or cancer care team for information about support groups near you.

Third-party websites being linked to are neither owned or controlled by Pfizer.
Pfizer does not endorse and is not responsible for the content or services of these sites.

XALKORI® (crizotinib) Rx Resources | Safety Info
Learn about personalized patient support & find downloadable resources for XALKORI®, an Rx option for ALK+ or ROS1+ mNSCLC. See risks & benefits.